Aldeyra Therapeutics to Participate in Fireside Chat at the SVB Securi...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 24, 2024

Benchmark Senior Living at Hamden Assisted Living Community Named One of the Country's Best by U.S. News & World Report • Motlow State Community College Expands Accessibility With the Addition of YuJa Panorama Digital Accessibility Platform to Its Ed • Santiago, Chile Will Host the 2027 Special Olympics World Games • Orion S.A. Earns Platinum Sustainability Rating by EcoVadis • PONIX AWARDED $5 MILLION USDA GRANT TO BREAK "GROUND" ON CLIMATE-SMART AGRICULTURE IN GEORGIA • QuantumScape Reports First Quarter 2024 Business and Financial Results • Voices for Humanity Bears Witness to Panama's Moral Resurgence With Giselle Lima • Asahi Kasei to Construct a Lithium-ion Battery Separator Plant in Canada • Wounded Warrior Project, White House Celebrate and Honor Warriors at Annual Soldier Ride • Leading Industry Publication: Black & Veatch Remains Among Global Critical Infrastructure Leaders as Sustainability, Decarbo • Arcosa Publishes 2023 Sustainability Report • ACTS LAW Addresses Federal Correctional Institution in Dublin Controversy • Ouro Teams Up with Texas One Fund with Multi-Year NIL X World Wallet Financial Empowerment Program for University of Texas Stude • ESS Inc. Schedules First Quarter 2024 Financial Results Conference Call • WM Announces First Quarter 2024 Earnings • White House Correspondents’ Association Dinner to Welcome Hooman Shahidi, Co-founder and CEO of EVPassport, the Rapidly Gr • ERVIN COHEN & JESSUP PARTNER RECOGNIZED AS TOP LAWYER IN LOS ANGELES • The Birches at Concord Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Third Strai • The Village at Willow Crossings Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Th • Bay Square at Yarmouth Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Third Strai

Aldeyra Therapeutics to Participate in Fireside Chat at the SVB Securities Global Biopharma Conference

LEXINGTON, Mass. , February 09 /Businesswire/ - Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company developing innovative therapies for the treatment of immune-mediated diseases, today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the SVB Securities Global Biopharma Conference. The conference is being conducted in a virtual format February 14-16, 2023.

Dr. Brady’s conversation with Marc Goodman, Senior Research Analyst at SVB Securities, is scheduled to begin at 10:00 a.m. ET Thursday, February 16, 2023. To view the live webcast, log in to the Investors & Media section of the Aldeyra website at https://ir.aldeyra.com. Following the fireside chat, the webcast will be archived for 90 days.

About Aldeyra

Aldeyra Therapeutics is a clinical-stage biotechnology company developing innovative therapies designed to treat immune-mediated diseases. Our approach is to discover pharmaceuticals that modulate immunological systems, instead of directly inhibiting or activating single protein targets, with the goal of optimizing multiple pathways at once while minimizing toxicity. Our pre-commercial product candidates are reproxalap, a potential treatment for dry eye disease and allergic conjunctivitis, and ADX-2191, a potential treatment for primary vitreoretinal lymphoma, proliferative vitreoretinopathy, and retinitis pigmentosa. In addition, we are developing other product candidates, including ADX-629 and chemically related molecules, for the potential treatment of systemic and retinal immune-mediated diseases. For more information, visit https://www.aldeyra.com/ and follow us on LinkedIn, Facebook, and Twitter.